Alexander Ambinder
SKCCC Johns Hopkins Medical Institution
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Alexander Ambinder as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:57 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05716009 · Tagraxofusp-erzs, an IL-3 Diphtheria Fusion Protein, in Combination With Gemtuzumab Ozogamicin in Patients With Relapsed/Refractory AMLSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · terminated · Acute Myeloid Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 22:57 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 22:57 UTC. The ranking covers the 200 most relevant of 5 PubMed records, and a shared surname and initials can bring in a namesake. All 5 on PubMed
- A comprehensive support program: effect on depression in spouse-caregivers of AD patients.Gerontologist · 1995204 citationsRCR 8.9
- An intervention that delays institutionalization of Alzheimer's disease patients: treatment of spouse-caregivers.Gerontologist · 1993183 citationsRCR 9.1
- 94 citationsRCR 3.5
- Nonmyeloablative, HLA-Mismatched Unrelated Peripheral Blood Transplantation with High-Dose Post-Transplantation Cyclophosphamide.Transplant Cell Ther · 202115 citationsRCR 1.1
- Bone marrow transplantation for sickle cell disease using posttransplantation cyclophosphamide and 400 cGy TBI.Blood Adv · 20266 citationsRCR 3.0